Ethereum faces weak institutional demand and lacks catalysts, keeping ETH price tied to broader altcoin trends and economic uncertainty.
You might also be interested in reading Cannara Biotech GAAP EPS of C$0.03, revenue of C$25.1M.
Ethereum faces weak institutional demand and lacks catalysts, keeping ETH price tied to broader altcoin trends and economic uncertainty.
You might also be interested in reading Cannara Biotech GAAP EPS of C$0.03, revenue of C$25.1M.